These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33239360)

  • 1. A second mechanism employed by artemisinins to suppress Plasmodium falciparum hinges on inhibition of hematin crystallization.
    Ma W; Balta VA; West R; Newlin KN; Miljanić OŠ; Sullivan DJ; Vekilov PG; Rimer JD
    J Biol Chem; 2021; 296():100123. PubMed ID: 33239360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.
    de Villiers KA; Egan TJ
    Acc Chem Res; 2021 Jun; 54(11):2649-2659. PubMed ID: 33982570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-Based Drugs Target the Plasmodium falciparum Heme Detoxification Pathway.
    Ribbiso KA; Heller LE; Taye A; Julian E; Willems AV; Roepe PD
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33495226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.
    Olafson KN; Nguyen TQ; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7531-7536. PubMed ID: 28559329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mode of action of quinoline antimalarial drugs in red blood cells infected by
    Kapishnikov S; Staalsø T; Yang Y; Lee J; Pérez-Berná AJ; Pereiro E; Yang Y; Werner S; Guttmann P; Leiserowitz L; Als-Nielsen J
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):22946-22952. PubMed ID: 31659055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Free Ferriprotoporphyrin IX Heme and Hemozoin for Artemisinin Sensitive versus Delayed Clearance Phenotype Plasmodium falciparum Malarial Parasites.
    Heller LE; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6927-6934. PubMed ID: 30513202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin-Ferriprotoporphyrin IX Adduct Abundance in Plasmodium falciparum Malarial Parasites and the Relationship to Emerging Artemisinin Resistance.
    Heller LE; Goggins E; Roepe PD
    Biochemistry; 2018 Dec; 57(51):6935-6945. PubMed ID: 30512926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials.
    Tripathi AK; Gupta A; Garg SK; Tekwani BL
    Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lipocalin mediates unidirectional heme biomineralization in malaria parasites.
    Matz JM; Drepper B; Blum TB; van Genderen E; Burrell A; Martin P; Stach T; Collinson LM; Abrahams JP; Matuschewski K; Blackman MJ
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16546-16556. PubMed ID: 32601225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite.
    Pandey AV; Tekwani BL; Singh RL; Chauhan VS
    J Biol Chem; 1999 Jul; 274(27):19383-8. PubMed ID: 10383451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms of action and resistance of Plasmodium falciparum to artemisinin.
    Phompradit P; Chaijaroenkul W; Na-Bangchang K
    Parasitol Res; 2017 Dec; 116(12):3331-3339. PubMed ID: 29127525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclassical mechanisms to irreversibly suppress β-hematin crystal growth.
    Ma W; Balta VA; Pan W; Rimer JD; Sullivan DJ; Vekilov PG
    Commun Biol; 2023 Jul; 6(1):783. PubMed ID: 37500754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine.
    Olafson KN; Ketchum MA; Rimer JD; Vekilov PG
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):4946-51. PubMed ID: 25831526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs.
    Witkowski B; Lelièvre J; Nicolau-Travers ML; Iriart X; Njomnang Soh P; Bousejra-Elgarah F; Meunier B; Berry A; Benoit-Vical F
    PLoS One; 2012; 7(3):e32620. PubMed ID: 22403683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction of artemisinin with malarial hemozoin.
    Hong YL; Yang YZ; Meshnick SR
    Mol Biochem Parasitol; 1994 Jan; 63(1):121-8. PubMed ID: 8183310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel way to grow hemozoin-like crystals in vitro and its use to screen for hemozoin inhibiting antimalarial compounds.
    Thomas V; Góis A; Ritts B; Burke P; Hänscheid T; McDonnell G
    PLoS One; 2012; 7(7):e41006. PubMed ID: 22815894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neutral lipid composition present in the digestive vacuole of Plasmodium falciparum concentrates heme and mediates β-hematin formation with an unusually low activation energy.
    Hoang AN; Sandlin RD; Omar A; Egan TJ; Wright DW
    Biochemistry; 2010 Nov; 49(47):10107-16. PubMed ID: 20979358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of hemozoin formation in Plasmodium falciparum trophozoite extracts by heme analogs: possible implication in the resistance to malaria conferred by the beta-thalassemia trait.
    Martiney JA; Cerami A; Slater AF
    Mol Med; 1996 Mar; 2(2):236-46. PubMed ID: 8726466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.